Express Scripts' Three-Year Drug Trend Forecast Projects That Three of the Four Costliest Therapy Classes Will Be Specialty Conditions ST. LOUIS, May...
Study Shows Effects of Treatment with ABILIFY MAINTENA™ (Aripiprazole) on Psychiatric Hospitalization Rates for Patients with Schizophrenia...
Vortioxetine, a new multimodal agent in development for the treatment of major depression, shows effects on cognitive function in several preclinical...
The mess that is Ranbaxy Laboratories is growing more intriguing every day. One day after Daiichi Sankyo issued a statement charging “certain former...
As the day winds on, we thought you may like to see a few of the latest items moving over the transom. Hope these help you enjoy your break still more...
Forest Labs Partners With Microbia (Yahoo/AP)
Depomed Cutting Jobs After Nerve Drug Fails (Bloomberg News)
Angiotech Settles Patent Dispute With J&J Unit (Yahoo/AP)
FDA And Gene Logic To Set Genomic Standards (DrugResearcher.com)
